{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T01:58:51Z","timestamp":1648864731589},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1157\/13108707","type":"journal-article","created":{"date-parts":[[2007,8,13]],"date-time":"2007-08-13T15:06:34Z","timestamp":1187017594000},"page":"437-440","source":"Crossref","is-referenced-by-count":9,"title":["Resistencias primarias a los f\u00e1rmacos antirretrovirales en los pacientes diagnosticados de infecci\u00f3n por el VIH en Gran Canaria entre los a\u00f1os 2002-2005"],"prefix":"10.1016","volume":"25","author":[{"given":"M\u00f3nica","family":"S\u00e1nchez O\u00f1oro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Pena L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"C\u00e1rdenes Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Zarzalejos And\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Artiles Campelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13108707_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1157\/13108707_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.288.2.181","article-title":"Time trends in primary HIV-1 drug resistance among recently infected persons","volume":"288","author":"Grant","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13108707_bib3","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study","year":"2005","journal-title":"BMJ"},{"key":"10.1157\/13108707_bib4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"Wensing","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1157\/13108707_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM199807303390504","article-title":"Sexual transmision of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors","volume":"339","author":"Hecht","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1157\/13108707_bib6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/jama.282.12.1135","article-title":"HIV-1 Drug resistance in newly infected individuals","volume":"282","author":"Boden","year":"1999","journal-title":"JAMA"},{"key":"10.1157\/13108707_bib7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.282.12.1142","article-title":"Reduced antiretroviral drug susceptibility among patients with primary HIV infection","volume":"282","author":"Little","year":"1999","journal-title":"JAMA"},{"key":"10.1157\/13108707_bib8","first-page":"53","article-title":"Documento de consenso de GESIDA sobre la utilizaci\u00f3n de los estudios de resistencias en la pr\u00e1ctica cl\u00ednica","volume":"19","author":"Gatell","year":"2001","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13108707_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/375597","article-title":"Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type1: 2003 Recommendations of an International AIDS Society-USA Panel","volume":"37","author":"Hirsch","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13108707_bib10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199810293391801","article-title":"Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 team","volume":"339","author":"Havlir","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1157\/13108707_bib11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/00002030-200312050-00011","article-title":"Stable prevalence of genotypic drug resistance mutations but increase in non-B virus infection in France","volume":"17","author":"Chaix","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13108707_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.qai.0000214805.52723.c1","article-title":"Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing","volume":"41","author":"Oette","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13108707_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0213-005X(05)75040-0","article-title":"Prevalencia de resistencia a los f\u00e1rmacos antirretrovirales en pacientes espa\u00f1oles infectados por el VIH y sin tratamiento previo","volume":"23","author":"Guerrero","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13108707_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/431203","article-title":"Antiretroviral recommendations may influence the rate of transmisi\u00f3n of drug-resistant HIV type 1","volume":"41","author":"De Mendoza","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T06:25:19Z","timestamp":1546669519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X07743276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0213005X07743276"],"URL":"https:\/\/doi.org\/10.1157\/13108707","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}